These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma. Wyse E; Handa JT; Friedman AD; Pearl MS Pediatr Radiol; 2016 Aug; 46(9):1223-33. PubMed ID: 26886915 [TBL] [Abstract][Full Text] [Related]
12. Intra-arterial chemotherapy for retinoblastoma: the beginning of a long journey. Shields CL; Shields JA Clin Exp Ophthalmol; 2010 Aug; 38(6):638-43. PubMed ID: 20584015 [TBL] [Abstract][Full Text] [Related]
13. Chemosurgery for retinoblastoma: what we know after 5 years. Abramson DH Arch Ophthalmol; 2011 Nov; 129(11):1492-4. PubMed ID: 22084221 [No Abstract] [Full Text] [Related]
14. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma. Hutchinson A; Kaliki S; Shields CL J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791 [No Abstract] [Full Text] [Related]
17. Outcome of intra-arterial chemotherapy for retinoblastoma and its influencing factors: a retrospective study. Chen M; Jiang H; Zhang J; Shen G; Jiang Y; Li H; Liu Z Acta Ophthalmol; 2017 Sep; 95(6):613-618. PubMed ID: 27874261 [TBL] [Abstract][Full Text] [Related]